Abstract:Introduction: Given the limited success to date in using non-specific membrane makers, in identifying cardiac stem cells, the significance of finding a much more potential cardiac mesenchymal stem cell (C-MSC) maker from transcription factors in nuclear is very important. Hypothesis: We want to test the feasibility of using GATA4, an early cardiac-specific transcription factor, as biomarker to identify a subpopulation of C-MSC that could be highly efficacious for cardiovascular repair. Methods: A lentiviral vector in which the expression of eGFP reporter is driven by a 1kb fragment of the mouse GATA4 promoter was constructed. Murine C-MSC with high GFP intensity were sorted by FACS. Results: Western blot shows that the C-MSC population with high GFP intensity exhibits higher GATA4 protein expression as compared with unsorted C-MSC. Interestingly, we observed that sorted GATA4high C-MSC also exhibit higher HIF-1α protein expression as compared with unsorted C-MSC. We compared hypoxia- and serum deprivation induced-apoptosis between sorted GATA4high and unsorted C-MSC by TUNEL staining. We found that the GATA4high exhibited lower rate of TUNEL positivity as compared with unsorted C-MSC, suggesting GATA4high C-MSC are more resistant to hypoxia- and serum deprivation-induced apoptosis in comparison with unsorted C-MSC. In mouse model of myocardial infarction by permanent left coronary ligation, GATA4high C-MSC or unsorted C-MSC was injected into the border zone area. Left ventricular ejection fraction (EF) were serially (days 1 and 14) assessed using echocardiography. At day 1, no differences in EF were observed between GATA4high C-MSC and unsorted C-MSC group (n=9, ns). At day 14, left ventricular ejection fraction in GATA4high C-MSC cell-treated group was improved about 11.2% compared with the unsorted C-MSC group (n=9, P Conclusions: Our results suggest that GATA4high, as compared with unsorted C-MSC, exhibit enhanced survival capacity which will consequently lead to improvement of heart contractile function in the infarcted heart, therefore, GATA4high C-MSC can be considered as a much more potential progenitor for heart repair.

GDF11 Enhances Therapeutic Efficacy of Mesenchymal Stem Cells for Myocardial Infarction Via YME1L-mediated OPA1 Processing.

Gdf11 Enhances Therapeutic Functions Of Mesenchymal Stem Cells For Angiogenesis

Retraction Note: GDF11 Enhances Therapeutic Functions of Mesenchymal Stem Cells for Angiogenesis

SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction.

Abstract 723: Agonist of Growth Hormone Releasing Hormone Enhances Angiogenic Therapy by Mesenchymal Stem Cells

Exogenous GDF11 attenuates non-canonical TGF-β signaling to protect the heart from acute myocardial ischemia-reperfusion injury

Growth Differentiation Factor 11 Promotes Differentiation of MSCs into Endothelial-Like Cells for Angiogenesis

Cardioprotective role of growth/differentiation factor 1 in post-infarction left ventricular remodelling and dysfunction.

NGF nanoparticles enhance the potency of transplanted human umbilical cord mesenchymal stem cells for myocardial repair

Abstract 19996: Cardiac Mesenchymal Stem Cells with High Endogenous Gata4 Promoter Activity Have Superior Capacity to Elicit Cardiac Repair

Effects of Hepatocyte Growth Factor Overexpressed Bone Marrow‐derived Mesenchymal Stem Cells on Prevention from Left Ventricular Remodelling and Functional Improvement in Infarcted Rat Hearts

Pretreatment with growth differentiation factor 15 augments cardioprotection by mesenchymal stem cells in myocardial infarction by improving their survival

Hepatoma-Derived Growth Factor Secreted from Mesenchymal Stem Cells Reduces Myocardial Ischemia-Reperfusion Injury.

GDF11 Alleviates Pathological Myocardial Remodeling in Diabetic Cardiomyopathy Through SIRT1-Dependent Regulation of Oxidative Stress and Apoptosis

Follistatin-like 1 Protects Mesenchymal Stem Cells from Hypoxic Damage and Enhances Their Therapeutic Efficacy in a Mouse Myocardial Infarction Model

VEGF/SDF-1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart.

SDF-1/CXCR4 Axis Modulates Bone Marrow Mesenchymal Stem Cell Apoptosis, Migration and Cytokine Secretion

Overexpression of Csx/Nkx2.5 and GATA-4 Enhances the Efficacy of Mesenchymal Stem Cell Transplantation after Myocardial Infarction

GDF11 Improves Angiogenic Function of EPCs in Diabetic Limb Ischemia.

Ghrelin Improves Functional Survival of Engrafted Adipose-Derived Mesenchymal Stem Cells in Ischemic Heart Through PI3K/Akt Signaling Pathway.

MSCs transplantation with application of G-CSF reduces apoptosis or increases VEGF in rabbit model of myocardial infarction